Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |